ArticleJournal of translational medicine2024

TRIM26 inhibits clear cell renal cell carcinoma progression through destabilizing ETK and thus inactivation of AKT/mTOR signaling.

Di Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.